##########
## COPD ##
##########
## ICD-9-CM Vol. 1
CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ALLIED CONDITIONS (490-496)
491 Chronic bronchitis
    491.0 Simple chr bronchitis
    491.1 Mucopurul chr bronchitis
    491.2 Obstructive chronic bronchitis
        491.20 Obst chr bronc w/o exac
        491.21 Obst chr bronc w(ac) exac
        491.22 Obst chr bronc w ac bronc
    491.8 Chronic bronchitis NEC
    491.9 Chronic bronchitis NOS
492 Emphysema
    492.0 Emphysematous bleb
    492.8 Emphysema NEC
493 Asthma
    493.2 Chronic obstructive asthma
        493.20 Chronic obst asthma NOS
        493.21 Ch ob asthma w stat asth
        493.22 Ch obst asth w (ac) exac
494 Bronchiectasis 
    494.0 Bronchiectas w/o ac exac
    494.1 Bronchiectasis w ac exac
495 Extrinsic allergic alveolitis
    495.0 Farmers lung
    495.1 Bagassosis
    495.2 Bird-fanciers lung
    495.3 Suberosis
    495.4 Malt workers lung
    495.5 Mushroom workers lung
    495.6 Mapl bark-stripprs lung
    495.7 Ventilation pneumonit
    495.8 Allerg alveol/pneum NEC
    495.9 Allerg alveol/pneum NOS
496 Chronic airway obstruction not elsewhere classified
    496 Chr airway obstruct NEC
OTHER METABOLIC AND IMMUNITY DISORDERS (270-279)
273 Disorders of plasma protein metabolism
    273.4 Alpha-1-antitrypsin def
PNEUMOCONIOSES AND OTHER LUNG DISEASES DUE TO EXTERNAL AGENTS (500-508)
500 Coal workers pneumoconiosis
501 Asbestosis
502 Pneumoconiosis due to other silica or silicates
503 Pneumoconiosis due to other inorganic dust
504 Pneumonopathy due to inhalation of other dust
505 Pneumoconiosis unspecified
506 Respiratory conditions due to chemical fumes and vapors
    506.4 Fum/vapor chr resp cond
507 Pneumonitis due to solids and liquids
508 Respiratory conditions due to other and unspecified external agents
OTHER DISEASES OF RESPIRATORY SYSTEM (510-519)
510 Empyema
511 Pleurisy
512 Pneumothorax and air leak
513 Abscess of lung and mediastinum
    513.0 Abscess of lung
514 Pulmonary congestion and hypostasis
    514 Pulm congest/hypostasis
515 Postinflammatory pulmonary fibrosis
    515 Postinflam pulm fibrosis
516 Other alveolar and parietoalveolar pneumonopathy
    516.0 Pul alveolar proteinosis
    516.1 Idio pulm hemosiderosis
    516.2 Pulm alveolar microlith
    516.3 Idiopathic interstitial pneumonia
        516.30 Idiopath inters pneu NOS
        516.31 Idiopath pulmon fibrosis
        516.32 Idio non-spec inter pneu
        516.33 Acute interstitial pneum
        516.34 Resp brncio interst lung
        516.35 Idiopth lym interst pneu
        516.36 Cryptogenic organiz pneu
        516.37 Desquamatv interst pneu
    516.6 Interstitial lung diseases of childhood
        516.61 Neuroend cell hyprpl inf
        516.62 Pulm interstitl glycogen
        516.63 Surfactant mutation lung
        516.64 Alv cap dysp w vn misaln
        516.69 Oth intrst lung dis chld
    516.8 Alveol pneumonopathy NEC
    516.9 Alveol pneumonopathy NOS
517 Lung involvement in conditions classified elsewhere
    517.1 Rheumatic pneumonia
    517.2 Syst sclerosis lung dis
    517.3 Acute chest syndrome
    517.8 Lung involv in oth dis
518 Other diseases of lung
    518.0 Pulmonary collapse
    518.1 Interstitial emphysema
    518.2 Compensatory emphysema
    518.3 Pulmonary eosinophilia
    518.4 Acute lung edema NOS
    518.5 Pulmonary insufficiency following trauma and surgery
        518.51 Ac resp flr fol trma/srg
        518.52 Ot pul insuf fol trm/srg
        518.53 Ac/chr rsp flr fol tr/sg
    518.6 Alrgc brncpul asprglosis
    518.7 Transfsn rel ac lung inj
    518.8 Other disease of lung
        518.81 Acute respiratry failure
        518.82 Other pulmonary insuff
        518.83 Chronic respiratory fail
        518.84 Acute & chronc resp fail
        518.89 Other lung disease NEC
519 Other diseases of respiratory system
    519.0 Tracheostomy complications
    519.1 Other diseases of trachea and bronchus, not elsewhere classified
    519.2 Mediastinitis
    519.3 Mediastinum disease NEC
    519.4 Disorders of diaphragm
    519.8 Resp system disease NEC
    519.9 Resp system disease NOS
## ## Cooke et al. 2011
## ## ## https://doi.org/10.1186/1472-6963-11-37
"We did not include 490 - Bronchitis, not specified as acute or chronic in
our administrative definition of COPD because the definition itself lacks
specificity which increases the concern about misclassification [23,24]."
491 Chronic bronchitis
492 Emphysema
493.2 Chronic obstructive asthma
496 Chronic airway obstruction NOC




############
## Cancer ##
############
## ICD-9-CM Vol. 1
NEOPLASMS (140-239)
MALIGNANT NEOPLASM OF LIP, ORAL CAVITY, AND PHARYNX (140-149)
MALIGNANT NEOPLASM OF DIGESTIVE ORGANS AND PERITONEUM (150-159)
MALIGNANT NEOPLASM OF RESPIRATORY AND INTRATHORACIC ORGANS (160-165)
MALIGNANT NEOPLASM OF BONE, CONNECTIVE TISSUE, SKIN, AND BREAST (170-176)
MALIGNANT NEOPLASM OF GENITOURINARY ORGANS (179-189)
MALIGNANT NEOPLASM OF OTHER AND UNSPECIFIED SITES (190-199)
    190 Malignant neoplasm of eye
        190.0 Malign neopl eyeball
        190.1 Malign neopl orbit
        190.2 Mal neo lacrimal gland
        190.3 Mal neo conjunctiva
        190.4 Malign neopl cornea
        190.5 Malign neopl retina
        190.6 Malign neopl choroid
        190.7 Mal neo lacrimal duct
        190.8 Malign neopl eye NEC
        190.9 Malign neopl eye NOS
    191 Malignant neoplasm of brain
        191.0 Malign neopl cerebrum
        191.1 Malig neo frontal lobe
        191.2 Mal neo temporal lobe
        191.3 Mal neo parietal lobe
        191.4 Mal neo occipital lobe
        191.5 Mal neo cereb ventricle
        191.6 Mal neo cerebellum NOS
        191.7 Mal neo brain stem
        191.8 Malig neo brain NEC
        191.9 Malig neo brain NO
    192 Malignant neoplasm of other and unspecified parts of nervous system
        192.0 Mal neo cranial nerves
        192.1 Mal neo cerebral mening
        192.2 Mal neo spinal cord
        192.3 Mal neo spinal meninges
        192.8 Mal neo nervous syst NEC
        192.9 Mal neo nervous syst NOS
    193 Malignant neoplasm of thyroid gland
    194 Malignant neoplasm of other endocrine glands and related structures
        194.0 Malign neopl adrenal
        194.1 Malig neo parathyroid
        194.3 Malig neo pituitary
        194.4 Malign neo pineal gland
        194.5 Mal neo carotid body
        194.6 Mal neo paraganglia NEC
        194.8 Mal neo endocrine NEC
        194.9 Mal neo endocrine NOS
    195 Malignant neoplasm of other and ill-defined sites
        195.0 Mal neo head/face/neck
        195.1 Malign neopl thorax
        195.2 Malig neo abdomen
        195.3 Malign neopl pelvis
        195.4 Malign neopl arm
        195.5 Malign neopl leg
        195.8 Malig neo site NEC
    196 Secondary and unspecified malignant neoplasm of lymph nodes
        196.0 Mal neo lymph-head/neck
        196.1 Mal neo lymph-intrathor
        196.2 Mal neo lymph intra-abd
        196.3 Mal neo lymph-axilla/arm
        196.5 Mal neo lymph-inguin/leg
        196.6 Mal neo lymph-intrapelv
        196.8 Mal neo lymph node-mult
        196.9 Mal neo lymph node NOS
    197 Secondary malignant neoplasm of respiratory and digestive systems
        197.0 Secondary malig neo lung
        197.1 Sec mal neo mediastinum
        197.2 Second malig neo pleura
        197.3 Sec malig neo resp NEC
        197.4 Sec malig neo sm bowel
        197.5 Sec malig neo lg bowel
        197.6 Sec mal neo peritoneum
        197.7 Second malig neo liver
        197.8 Sec mal neo GI NEC
    198 Secondary malignant neoplasm of other specified sites
        198.0 Second malig neo kidney
        198.1 Sec malig neo urin NEC
        198.2 Secondary malig neo skin
        198.3 Sec mal neo brain/spine
        198.4 Sec malig neo nerve NEC
        198.5 Secondary malig neo bone
        198.6 Second malig neo ovary
        198.7 Second malig neo adrenal
        198.8 Secondary malignant neoplasm of; other specified sites
            198.81 Second malig neo breast
            198.82 Second malig neo genital
            198.89 Secondary malig neo NEC
    199 Malignant neoplasm w/o specification of site
        199.0 Malig neo disseminated
        199.1 Malignant neoplasm NOS
        199.2 Malig neopl-transp organ
MALIGNANT NEOPLASM OF LYMPHATIC AND HEMATOPOIETIC TISSUE (200-208)
NEUROENDOCRINE TUMORS (209)
BENIGN NEOPLASMS (210-229)
CARCINOMA IN SITU (230-234)
NEOPLASMS OF UNCERTAIN BEHAVIOR (235-238)
NEOPLASMS OF UNSPECIFIED NATURE (239)
239 Neoplasms of unspecified nature
    239.0 Digestive neoplasm NOS
    239.1 Respiratory neoplasm NOS
    239.2 Bone/skin neoplasm NOS
    239.3 Breast neoplasm NOS
    239.4 Bladder neoplasm NOS
    239.5 Other gu neoplasm NOS
    239.6 Brain neoplasm NOS
    239.7 Endocrine/nerv neo NOS
    239.8 Neoplasms of unspecified nature; other specified sites
        239.81 Neo retina/choroid NOS
        239.89 Neoplasm other sites NOS
    239.9 Neoplasm NOS
DISEASES OF THE BLOOD AND BLOOD-FORMING ORGANS (280-289)
285 Other and unspecified anemias
    285.2 Anemia of chronic disease
        285.22 Anemia in neoplastic dis
    285.3  Anemia d/t antineo chemo
DISEASES OF VEINS AND LYMPHATICS, AND OTHER DISEASES OF CIRCULATORY SYSTEM (451-459)
457 Noninfectious disorders of lymphatic channels
    457.0 Postmastect lymphedema
    457.1 Other lymphedema
    457.2 Lymphangitis
    457.8 Noninfect lymph dis NEC
    457.9 Noninfect lymph dis NOS
DISEASES OF THE NERVOUS SYSTEM AND SENSE ORGANS (320-389)
338 Pain, not elsewhere classified
    338.3 Neoplasm related pain
V07.31 - Need for prophylactic fluoride administration
V07.39 - Other prophylac chemothr
V26.42 - Encounter for fertility preservation counseling
V26.82 - Encounter for fertility preservation procedure
PERSONS ENCOUNTERING HEALTH SERVICES FOR SPECIFIC PROCEDURES ... (V50-V59)
V51 Aftercare involving the use of plastic surgery
    V51.0 Brst reconst fol mastect
V58.0 Radiotherapy encounter
V58.1 Encounter for antineoplastic chemotherapy and immunotherapy
    V58.11 Antineoplastic chemo enc
    V58.12 Immunotherapy encounter
V58.4 Other aftercare following surgery
    V58.42 Aftercare neoplasm surg
PERSONS ENCOUNTERING HEALTH SERVICES IN OTHER CIRCUMSTANCES (V60-V69)
V66 Convalescence and palliative care
    V66.1 Radiotherapy convalescen
    V66.2 Chemotherapy convalescen
V67 Follow-up examination
    V67.1 Radiotherapy follow-up
    V67.2 Chemotherapy follow-up
## ## Ruck et al. 2018
## ## ## https://doi.org/10.1089/jpm.2018.0003
"Malignancy-related hospitalizations were identified by a primary ICD-9
 code between 140 and 239; data were then grouped by cancer type as per
 the American Medical Informatics Association system [24]."
## ## Weiner et al. 2003
## ## ## https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1480106/
"[...] inpatient and outpatient cancer [ICD-9] codes for a set of 70
 oncology patients without leukemia/lymphoma who were receiving
 ambulatory chemotherapy and were admitted within 30 days of
 [¿last dose of?] chemotherapy."
Melanoma                        172*
Breast                          174*, 175*, 239.3
Colon                           153*, 154*, 235.2
Gyn                             180*, 182*, 183*, 184*, 236.1, 236.2
Prostate                        185*, 236.5
Testes/Male GU                  186*, 187.3, 187.4, 187.9, 236.4, 236.6
Head and neck                   140–149.9, 160*, 161*, 162*, 195.0
Urinary Tract                   188*, 189*, 236.7, 236.91, 239.4, 239.5
Non-melanomatous skin cancer    173*, 238.2
Non-colon GI                    150–152.9, 155–159.9, 235*, 239.0
Lung                            162*, 235.9, 239.1
Brain                           190–192.9, 237.5, 237.6, 239.6
Bones/soft tissue               170*, 171*, 238.1, 238.2
Endocrine                       193,  194*, 237.0, 237.4, 239.7
Pleura/mediastinum              163*, 164*
Non-specific site               195*, 199*, 238.8, 238.9, 239.8, 239.9
Lymph node spread               196*
Secondary cancer                196*, 197*




#######################
## Metastatic cancer ##
#######################
## ICD-9-CM Vol. 1
CARCINOMA IN SITU (230-234)
MALIGNANT NEOPLASM OF OTHER AND UNSPECIFIED SITES (190-199)
196 Secondary and unspecified malignant neoplasm of lymph nodes
    196.1 Mal neo lymph-intrathor
    196.2 Mal neo lymph intra-abd
    196.3 Mal neo lymph-axilla/arm
    196.5 Mal neo lymph-inguin/leg
    196.6 Mal neo lymph-intrapelv
    196.8 Mal neo lymph node-mult
    196.9 Mal neo lymph node NOS
197 Secondary malignant neoplasm of respiratory and digestive systems
    197.0 Secondary malig neo lung
    197.1 Sec mal neo mediastinum
    197.2 Second malig neo pleura
    197.3 Sec malig neo resp NEC
    197.4 Sec malig neo sm bowel
    197.5 Sec malig neo lg bowel
    197.6 Sec mal neo peritoneum
    197.7 Second malig neo liver
    197.8 Sec mal neo GI NEC
198 Secondary malignant neoplasm of other specified sites
    198.0 Second malig neo kidney
    198.1 Sec malig neo urin NEC
    198.2 Secondary malig neo skin
    198.3 Sec mal neo brain/spine
    198.4 Sec malig neo nerve NEC
    198.5 Secondary malig neo bone
    198.6 Second malig neo ovary
    198.7 Second malig neo adrenal
    198.8 Secondary malignant neoplasm of; other specified sites
        198.81 Second malig neo breast
        198.82 Second malig neo genital
        198.89 Secondary malig neo NEC
199 Malignant neoplasm without specification of site
    199.0 Malig neo disseminated
NEUROENDOCRINE TUMORS (209)
209 Neuroendocrine tumors
    209.7 Secondary neuroendocrine tumors
        209.70 Sec neuroendo tumor NOS
        209.71 Sec neuroend tu dist lym
        209.72 Sec neuroend tumor-liver
        209.73 Sec neuroendo tumor-bone
        209.74 Sec neuroendo tu-periton
        209.75 Sec Merkel cell ca
        209.79 Sec neuroend tu oth site
## ## Thomas et al. 2002
## ## ## https://doi.org/10.1002/pds.759
"Advanced‐stage disease (stages II to IV) was defined by claims indicating
 lymph node involvement or metastases (ICD‐9 codes 196–199.1)."
## Tagliabue et al. 2006
## ## https://doi.org/10.1186/1478-7954-4-10
"We found a relatively high frequency of discrepancies involving cancer
 from unknown primary site. In 66% of these cases [ICD-9 code 199] was
 accompanied by specific site codes, but in all cases manual checking
 showed that the site codes were for metastatic or disseminated cancers,
 and it was never possible to identify the site of origin of the primary
 disease."




########################
## Hematologic cancer ##
########################
## ICD-9-CM Vol. 1
MALIGNANT NEOPLASM OF LYMPHATIC AND HEMATOPOIETIC TISSUE (200-208)
200 Lymphosarcoma and reticulosarcoma and other specified malignant tumors of lymphatic tissue
201 Hodgkins disease
202 Other malignant neoplasms of lymphoid and histiocytic tissue
203 Multiple myeloma and immunoproliferative neoplasms
204 Lymphoid leukemia
205 Myeloid leukemia
206 Monocytic leukemia
207 Other specified leukemia
208 Leukemia of unspecified cell type
DISEASES OF THE BLOOD AND BLOOD-FORMING ORGANS (280-289)
284.0 Constitutional aplastic anemia
284.1 Pancytopenia
284.2 Myelophthisis
    284.2 Myelophthisis
284.8 Other specified aplastic anemias
284.9 Aplastic anemia NOS
284 Aplastic anemia and other bone marrow failure syndromes
285 Other and unspecified anemias
286 Coagulation defects
287 Purpura and other hemorrhagic conditions
288 Diseases of white blood cells
289 Other diseases of blood and blood-forming organs
    289.8 Other specified diseases of blood and blood-forming organs
        289.81 Prim hypercoagulable st
        289.82 Sec hypercoagulable st
        289.83 Myelofibrosis
        289.84 Heparin-indu thrombocyto
        289.89 Blood diseases NEC
## Tagliabue et al. 2006
## ## https://doi.org/10.1186/1478-7954-4-10
"Phekoo et al. found that 20% of [hematologic cancer] cases had discordant
 diagnoses."




####################################
## Diabetes ("insulin requiring") ##
####################################
## MIMIC-III
## ## D_ITEMS.ITEMID
## ## ## Insulin
7914    ## Insulin Guideline
7920    ## humalog insulin pump
4475    ## Insulin
2432    ## insulin
2869    ## PORK INSULIN U/HR
6232    ## reg insulin
42763   ## PORK INSULIN GTT
30310   ## Insulin Drip
30045   ## Insulin
30100   ## Regular Insulin
44354   ## insulin carrier
44518   ## Insulin Carrier
45186   ## Insulin carrier
45322   ## NS Insulin Carrier
223257  ## Insulin - 70/30
223258  ## Insulin - Regular
223259  ## Insulin - NPH
223260  ## Insulin - Glargine
223261  ## Insulin - Humalog 75/25
223262  ## Insulin - Humalog
228236  ## Insulin pump
## ICD-9-CM Vol. 1
## ## Insulin
PERSONS ENCOUNTERING HEALTH SERVICES FOR SPECIFIC PROCEDURES ... (V50-V59)
V58 Encounter for other and unspecified procedures and aftercare
    V53 Fitting and adjustment of other device
        V53.9 Other and unspecified device
            V53.91 Fit/adjust insulin pump
        V58.6 Long-term (current) drug use
            V58.67 Long-term use of insulin
PERSONS ENCOUNTERING HEALTH SERVICES IN OTHER CIRCUMSTANCES (V60-V69)
V65 Other persons seeking consultation
    V65.4 Other counseling, not elsewhere classified
        V65.46 Insulin pump training
DRUGS, MEDICINAL AND BIOLOGICAL SUBSTANCES CAUSING ADVERSE EFFECTS IN THERAPEUTIC USE (E930-E949)
E932 Hormones and synthetic substitutes causing adverse effects
    E932.3 Adv eff insulin/antidiab
## ## Diabetes mellitus
DISEASES OF OTHER ENDOCRINE GLANDS (249-259)
249 Secondary diabetes mellitus
250 Diabetes mellitus
    ## ## DMI
    250.01 DMI wo cmp nt st uncntrl
    250.03 DMI wo cmp uncntrld
    250.11 DMI keto nt st uncntrld
    250.13 DMI ketoacd uncontrold
    250.21 DMI hprsm nt st uncntrld
    250.23 DMI hprosmlr uncontrold
    250.31 DMI o cm nt st uncntrld
    250.33 DMI oth coma uncontrold
    250.41 DMI renl nt st uncntrld
    250.43 DMI renal uncntrld
    250.51 DMI ophth nt st uncntrld
    250.53 DMI ophth uncntrld
    250.61 DMI neuro nt st uncntrld
    250.63 DMI neuro uncntrld
    250.71 DMI circ nt st uncntrld
    250.73 DMI circ uncntrld
    250.81 DMI oth nt st uncntrld
    250.83 DMI oth uncntrld
    250.91 DMI unspf nt st uncntrld
    250.93 DMI unspf uncntrld
    ## ## DMII
    250.00 DMII wo cmp nt st uncntr
    250.02 DMII wo cmp uncntrld
    250.10 DMII keto nt st uncntrld
    250.12 DMII ketoacd uncontrold
    250.20 DMII hprsm nt st uncntrl
    250.22 DMII hprosmlr uncontrold
    250.30 DMII oth coma nt st uncntrld
    250.32 DMII oth coma uncontrold
    250.40 DMII renl nt st uncntrld
    250.42 DMII renal uncntrld
    250.50 DMII ophth nt st uncntrl
    250.52 DMII ophth uncntrld
    250.60 DMII neuro nt st uncntrl
    250.62 DMII neuro uncntrld
    250.70 DMII circ nt st uncntrld
    250.72 DMII circ uncntrld
    250.80 DMII oth nt st uncntrld
    250.82 DMII oth uncntrld
    250.90 DMII unspf nt st uncntrl
    250.92 DMII unspf uncntrld
COMPLICATIONS MAINLY RELATED TO PREGNANCY (640-649)
648.0 Diabetes mellitus in mother w/ complications
    ## ## Gestational diabetes
    648.00 Diabetes in preg-unspec
    648.01 Diabetes-delivered
    648.02 Diabetes-delivered w p/p
    648.03 Diabetes-antepartum
    648.04 Diabetes-postpartum
## Yeaw et al. 2012
## ## https://doi.org/10.18553/jmcp.2012.18.1.21.
## ## ## https://s3.amazonaws.com/ajmc/_media/_pdf/AJMC_02_2018_Agiro%20eAppendix.pdf
Type 1 DM diagnosis 
    ICD-9-CM Codes
        250.x1, 250.x3, V53.91 
    GPI Codes
        2710
Diabetes diagnoses
    ICD-9-CM Codes
        250.xx, 357.2x, 362.0x, 366.41, 648.0x
Oral antidiabetic drug medication
    GPI Codes
        2750, 2715, 2799, 2710, 2728, 2717, 2755, 2720, 2760
Diabetic testing strips 
    GPI Codes
        94100030006100, 94100030009800, 94100030006000
Basal insulin
    GPI Codes
        27104003, 27104006, 27101020, 27101040,
        27102040, 27103020, 27103040, 27104020,
        27104030, 27101050, 27101030, 27102030,
        27102050, 27103030, 27104050, 27102020
Bolus insulin
    GPI Codes
        27104005, 27104002, 27104004, 27101010,
        27101060, 27102010, 27102060, 27103010,
        27103060, 27104010, 27104015
Premixed insulin
    GPI Codes
        27104080, 27104070, 27103070, 27104090




#################################
## Heart failure (NYHA III/IV) ##
#################################
## ICD-9-CM Vol. 1
## ## Heart failure
## ## ## NOTE: No ICD-9 codes direcctly correspond with NYHA classes
OTHER FORMS OF HEART DISEASE (420-429)
    428 Heart failure
        428.0 CHF NOS
        428.1 Left heart failure
        428.2 Systolic heart failure
        428.3 Diastolic heart failure
        428.4 Combined systolic and diastolic heart failure
        428.9 Heart failure NOS




###########################
## Chronic renal failure ##
###########################
## ICD-9-CM Vol. 1
## ## Chronic kidney disease 
NEPHRITIS, NEPHROTIC SYNDROME, AND NEPHROSIS (580-589)
585 Chronic kidney disease (CKD)
    585.1 Chro kidney dis stage I
    585.2 Chro kidney dis stage II
    585.3 Chr kidney dis stage III
    585.4 Chr kidney dis stage IV
    585.5 Chron kidney dis stage V
    585.6 End stage renal disease
    585.9 Chronic kidney dis NOS
HYPERTENSIVE DISEASE (401-405)
403 Hypertensive chronic disease
    403.0 Malignant hypertensive kidney disease
        403.00 Mal hy kid w cr kid I-IV
        403.01 Mal hyp kid w cr kid V
    403.1 Benign hypertensive kidney disease
        403.10 Ben hy kid w cr kid I-IV
        403.11 Ben hyp kid w cr kid V
    403.9 Unspecified hypertensive kidney disease
        403.90 Hy kid NOS w cr kid I-IV
        403.91 Hyp kid NOS w cr kid V
404 Hypertensive heart and chronic disease
    404.0 Malignant hypertensive heart and disease
        404.00 Mal hy ht/kd I-IV w/o hf
        404.01 Mal hyp ht/kd I-IV w hf
        404.02 Mal hy ht/kd st V w/o hf
        404.03 Mal hyp ht/kd stg V w hf
    404.1 Benign hypertensive heart and disease
        404.10 Ben hy ht/kd I-IV w/o hf
        404.11 Ben hyp ht/kd I-IV w hf
        404.12 Ben hy ht/kd st V w/o hf
        404.13 Ben hyp ht/kd stg V w hf
    404.9 Unspecified hypertensive heart and disease
        404.90 Hy ht/kd NOS I-IV w/o hf
        404.91 Hyp ht/kd NOS I-IV w hf
        404.92 Hy ht/kd NOS st V w/o hf
        404.93 Hyp ht/kd NOS st V w hf
## ## Dialysis
PERSONS WITH A CONDITION INFLUENCING THEIR HEALTH STATUS (V40-V49)
V45 Other postprocedural states
    V45.1 Renal dialysis status postprocedural state
        V45.11 Renal dialysis status
        V45.12 Noncmplnt w renal dialys
PERSONS ENCOUNTERING HEALTH SERVICES FOR SPECIFIC PROCEDURES ... (V50-V59)
V56 Encounter for dialysis and dialysis catheter care
    V56.0 Renal dialysis encounter
    V56.1 Ft/adj xtrcorp dial cath
    V56.2 Fit/adj perit dial cath
    V56.3 Encounter for adequacy testing for dialysis
        V56.31 Hemodialysis testing
        V56.32 Peritoneal dialysis test
    V56.8 Dialysis encounter, NEC
SURG & MEDICAL PROCEDURES AS CAUSE OF ABNORMAL PATIENT ... (E878-E879)
E879 Other procedures without mention of misadventure at the time of ...
    E879.1  Abn react-renal dialysis
OPERATIONS ON THE CARDIOVASCULAR SYSTEM (35-39)
39 Other operations on vessels
    39.2 Other shunt or vascular bypass
        39.27 Arteriovenostomy for renal dialysis
    39.9 Other operations on vessels
        39.95 Hemodialysis
        39.42 Revision of arteriovenous shunt for renal dialysis
        39.43 Removal of arteriovenous shunt for renal dialysis
        38.95 Venous catheterization for renal dialysis
OPERATIONS ON THE DIGESTIVE SYSTEM (42-54)
54 Other operations on abdominal region
    54.9 Other operations of abdominal region
        54.98 Peritoneal dialysis
NONSPECIFIC ABNORMAL FINDINGS (790-796)
792 Nonspecific abnormal findings in other body substances
    792.5 Cloudy dialysis effluent
COMPLICATIONS OF SURG AND MEDICAL CARE, NOT ELSEWHERE CLASSIFIED (996-999)
996 Complications peculiar to certain specified procedures
    996.5 Mech compl other specified prosthetic device, implant, graft
        996.56 Comp-periton dialys cath
    996.6 Infection and inflammation to prosthetic device, implant, graft
        996.68 React-periton dialy cath
    996.7 Other complications of internal device, implant, and graft
        996.73 Comp-ren dialys dev/grft




###################
## HIV infection ##
###################
## ICD-9-CM Vol. 1
## ## HIV-1/2
HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION (042-042)
042 Human immunodeficiency virus [HIV] disease
    042 Human immuno virus dis
OTHER DISEASES DUE TO VIRUSES AND CHLAMYDIAE (070-079)
079 Viral and chlamydial infection in conditions CE and unspecified site
    079.5 Retrovirus
        079.53 HIV-2 infection oth dis
INTESTINAL INFECTIOUS DISEASES (001-009)
    007.2 Coccidiosis
OTHER METABOLIC AND IMMUNITY DISORDERS (270-279)
    272 Disorders of lipoid metabolism
        272.6 Lipodystrophy
NONSPECIFIC ABNORMAL FINDINGS (790-796)
795 Other and nonspecific ... test findings
    795.7 Other nonspecific immunological findings
        795.71 Nonspecific Evidence of HIV
V08 Asymptomatic human immunodeficiency virus [HIV] infection status
    V08 Asymptomatic HIV+ status
PERSONS ENCOUNTERING HEALTH SERVICES IN OTHER CIRCUMSTANCES (V60-V69)
V65 Other persons seeking consultation
    V65.44 HIV counseling
SUPPLEMENTARY CLASS ... CONTACT W HEALTH SERVICES (V01-V91)
V72 Special investigations and examinations
    V72.6 Laboratory examination
        V72.60 Laboratory exam NOS
        V72.61 Antibody response exam
        V72.62 Routine physicl lab exam
        V72.63 Pre-procedure lab exam
        V72.69 Laboratory exam NEC
## ## Superinfections and sequelae
## ## ## Kaposi Sarcoma
VIRAL DISEASES ACCOMPANIED BY EXANTHEM (050-059)
058 Other human herpesvirus
    058.8 Other human herpesvirus infections
        058.89 Other human herpesvirus infection
## ## ## PML
POLIO AND OTHER NON-ARTHOPOD VIRAL AND PRION DISEASES OF THE CNS (045-049)
046 Slow virus infections and prion diseases of central nervous system
    046.3 Progressive multifocal leukoencephalopathy
## ## ## CMV
PNEUMONIA AND INFLUENZA (480-488)
484 Pneumonia in infectious diseases classified elsewhere
    484.1 Pneum w cytomeg incl dis
## ## ## Pneumocystis pneumonia
OTHER INFECTIOUS AND PARASITIC DISEASES (130-136)
136 Other and unspecified infectious and parasitic diseases
    136.3 Pneumocystosis
## ## ## Crypto
INFLAMMATORY DISEASES OF THE CENTRAL NERVOUS SYSTEM (320-326)
321 Meningitis due to other organisms
    321.0 Cryptococcal meningitis
## ## ## Toxo
OTHER INFECTIOUS AND PARASITIC DISEASES (130-136)
130 Toxoplasmosis
    130.0 Toxoplasm meningoenceph
    130.1 Toxoplasm conjunctivitis
    130.2 Toxoplasm chorioretinit
    130.3 Toxoplasma myocarditis
    130.4 Toxoplasma pneumonitis
    130.5 Toxoplasma hepatitis
    130.7 Toxoplasmosis site NEC
    130.8 Multisystem toxoplasmos
    130.9 Toxoplasmosis NOS
## CDC WONDER 1998
## ## https://wonder.cdc.gov/wonder/prevguid/m0032908/m0032908.asp
"The current 042-044 series of codes has been replaced with a single code,
 042, for HIV disease. A new code, V08, has been created for asymptomatic 
 HIV infection. Code 795.8 has been deleted and a new code, 795.71, 
 Inconclusive serological findings for Human Immunodeficiency Virus (HIV), 
 has been created. This code will include inconclusive HIV test findings 
 in infants. [...]. Patients with inconclusive HIV serology, but no 
 definitive diagnosis or manifestations of the illness may be assigned
 code 795.71. [...] Code V72.6 Laboratory examination, should be assigned
 for patients seen only for HIV testing."
##  Freiberg et al. 2011
## ## https://doi.org/10.1161/circoutcomes.110.957415
"HIV infection was defined as a participant with 1 inpatient and/or 2
 outpatient International Classification of Diseases (ICD)-9 codes for HIV
 infection and confirmed by the participant’s presence in the immunology
 case registry."




###############
## Cirrhosis ##
###############
## ICD-9-CM Vol. 1/2
OTHER DISEASES OF DIGESTIVE SYSTEM (570-579)
570 Acute and subacute necrosis of liver
    570 Acute necrosis of liver
571 Chronic liver disease and cirrhosis
    571.0 Alcoholic fatty liver
    571.1 Ac alcoholic hepatitis
    571.2 Alcohol cirrhosis liver
    571.3 Alcohol liver damage NOS
    571.4 Chronic hepatitis
        571.40 Chronic hepatitis NOS
        571.41 Chr persistent hepatitis
        571.42 Autoimmune hepatitis
        571.49 Chronic hepatitis NEC
    571.5 Cirrhosis of liver NOS
    571.6 Biliary cirrhosis
    571.8 Chronic liver dis NEC
    571.9 Chronic liver dis NOS
572 Liver abscess and sequelae of chronic liver disease
    572.2 Hepatic encephalopathy
    572.3 Portal hypertension
    572.4 Hepatorenal syndrome
576 Other disorders of biliary tract
    576.1 Cholangitis
## ## Correlates and sequelae
SYMPTOMS (780-789)
789 Other symptoms involving abdomen and pelvis
    789.1 Hepatomegaly
    789.5 Ascites
        789.59 Ascites NEC
DISEASES OF THE BLOOD AND BLOOD-FORMING ORGANS (280-289)
289.4 Hypersplenism
289.5 Other diseases of spleen
    289.51 Chr congest splenomegaly
OTHER DISEASES OF DIGESTIVE SYSTEM (570-579)
573 Other disorders of liver
    573.0 Chr passiv congest liver
    573.1 Hepatitis in viral dis
    573.2 Hepatitis in oth inf dis
    573.3 Hepatitis NOS
    573.4 Hepatic infarction
    573.5 Hepatopulmonary syndrome
    573.8 Liver disorders NEC
    573.9 Liver disorder NOS
DISEASES OF VEINS AND LYMPHATICS, AND OTHER DISEASES OF CIRCULATORY SYSTEM (451-459)
456 Varicose veins of other sites
    456.0 Esophageal varices with bleeding
    456.1 Esophageal varices without bleeding
    456.2 Varices in diseases classified elsewhere with bleeding
        456.20 Bleed esoph var oth dis
        456.21 Esoph varice oth dis NOS
## ## ## Hemochromatosis
OTHER METABOLIC AND IMMUNITY DISORDERS (270-279)
275.0 Disorders of iron metabolism
    275.01 Hereditary hemochromatosis
    275.03 Hemochromatosis NEC
## ## ## Wilson's disease
275.1 Disorders of copper metabolism
    275.1 Dis copper metabolism
DISORDERS OF THE EYE AND ADNEXA (360-379)
371 Corneal opacity and other disorders of cornea
    371.1 Corneal pigmentations and deposits
        371.14 Kayser-Fleischer ring
## ## ## Hepar lobatum
SYPHILIS AND OTHER VENEREAL DISEASES (090-099)
095 Other forms of late syphilis, with symptoms
    095.3 Syphilis of liver
## ## ## Spider angioma
DISEASES OF ARTERIES, ARTERIOLES, AND CAPILLARIES (440-449)
448 Disease of capillaries
    448.1 Nevus, non-neoplastic
    448.0 Heredit hemorr telangiec
## ## ## AATD, Abetalipoproteinemia, Tyrosinosis
OTHER METABOLIC AND IMMUNITY DISORDERS (270-279)
272 Disorders of lipoid metabolism
    272.5 Lipoprotein deficiencies 
273 Disorders of plasma protein metabolism
    273.4 Alpha-1-antitrypsin def 
    273.8 Dis plas protein met NEC
OTHER METABOLIC AND IMMUNITY DISORDERS (270-279)
270 Disorders of amino-acid transport and metabolism
    270.2 Other disturbances of aromatic amino-acid metabolism
## ## ## Pathological carb metabolism
271 Disorders of carbohydrate transport and metabolism
    271.0 Glycogenosis
    271.1 Galactosemia
    271.2 Hered fructose intoleran
## ## ## Granulomatosis
OTHER INFECTIOUS AND PARASITIC DISEASES (130-136)
135 Sarcoidosis
    135 Sarcoidosis
OTHER INFLAMMATORY CONDITIONS OF SKIN AND SUBCUTANEOUS TISSUE (690-698)
697 Lichen
    697.0 Lichen planus
## Nehra et al. 2014
## ## https://doi.org/10.1097/MCG.0b013e3182688d2f
"We did not include the ICD-9 code for biliary cirrhosis (571.6) as this
 code was often associated with early stage PBC or PSC instead of
 cirrhosis. [...] Most ICD-9 codes had sufficient specificity except
 cirrhosis without alcohol and ascites, which both had significantly lower
 specificities (p< .001 for both comparisons). Similarly, each of the
 codes had a high positive predictive value above 75%, except ascites,
 which had a significantly lower positive predictive value (p<0.001)."
## Chrostek et al. 2014
## ## https:/doi.org/10.1007/s10238-013-0262-5
"It should not be generalized that the levels of lipids and lipoproteins
 in liver cirrhosis progressively diminished with the deterioration of
 liver function. The serum HDL-Ch and LDL-Ch may be considered as markers
 of severity of liver damage in non-alcoholic cirrhosis, but the
 triglycerides only in disease of alcoholic origin."
## Krynytska et al. 2017
## ## https://doi.org/10.17305/bjbms.2017.2020
## ## ## NOTE: ## OWR sydrome => 448.0 - Heredit hemorr telangiec
"HPS is diagnosed in 4-47% of patients with cirrhosis and in 15-20% of
 candidates for liver transplantation. [...] The diagnosis of HHT is
 considered if at least three of the four diagnostic criteria are met:
 spontaneous, recurrent epistaxis, multiple telangiectases at different
 sites (lips, oral cavity, fingers, and nose), visceral lesions including
 gastrointestinal telangiectasia, pulmonary PAVMs, hepatic, cerebral and
 spinal AVMs, as well as family history of HHT."
## Blich
## ##  https://doi.org/10.1111/j.1440-1746.2003.03335.x
"Cirrhosis and portal hypertension are rare manifestations of sarcoid
 liver disease, each being found in less than 1% of patients with
 sarcoidosis."




#######################
## Immunosuppression ##
#######################
## ICD-9-CM Vol. 1
DISEASES OF OTHER ENDOCRINE GLANDS (249-259)
254 Diseases of thymus gland
    254.0 Persist hyperplas thymus
    254.1 Abscess of thymus
    254.8 Diseases of thymus NEC
    254.9 Disease of thymus NOS
OTHER METABOLIC AND IMMUNITY DISORDERS (270-279)
279 Disorders involving the immune mechanism
    279.0 Deficieny of humoral immunity
        279.00 Hypogammaglobulinem NOS
        279.01 Selective iga immunodef
        279.02 Selective IgM immunodef
        279.03 Selective ig defic NEC
        279.04 Cong hypogammaglobulinem
        279.05 Immunodefic w hyper-igm
        279.06 Common variabl immunodef
        279.09 Humoral immunity def NEC
    279.1 Deficiency of cell-mediated immunity
        279.10 Immundef t-cell def NOS
        279.11 Digeorge syndrome
        279.12 Wiskott-aldrich syndrome
        279.13 Nezelof syndrome
        279.19 Defic cell immunity NOS
    279.2 Combined immunity defic
    279.3 Immunity deficiency NOS
    279.4 Autoimmune disease, not elsewhere classified
        279.41 Autoimmun lymphprof synd
        279.49 Autoimmune disease NEC
    279.5 Graft-versus-host disease
        279.50 Graft-versus-host NOS
        279.51 Ac graft-versus-host dis
        279.52 Chronc graft-vs-host dis
        279.53 Ac on chrn grft-vs-host
    279.8 Immune mechanism dis NEC
    279.9 Immune mechanism dis NOS
DISEASES OF THE BLOOD AND BLOOD-FORMING ORGANS (280-289)
284 Aplastic anemia and other bone marrow failure syndromes
    284.1 Pancytopenia
        284.11 Antin chemo indcd pancyt
        284.12 Oth drg indcd pancytopna
        284.19 Other pancytopenia
288 Diseases of white blood cells
    288.0 Neutropenia
        288.00 Neutropenia NOS
        288.01 Congenital neutropenia
        288.02 Cyclic neutropenia
        288.03 Drug induced neutropenia
        288.04 Neutropenia d/t infectn
        288.09 Neutropenia NEC
    288.1 Function dis neutrophils
    288.2 Genetic anomaly leukocyt
    288.3 Eosinophilia
    288.4 Hemophagocytic syndromes
    288.5 Decreased white blood cell count category
        288.50 Leukocytopenia NOS
        288.51 Lymphocytopenia
        288.59 Decreased WBC count NEC
    288.6 Elevated white blood cell count category
        288.62 Leukemoid reaction
    288.8 WBC disease NEC
    288.9 WBC disease NOS
289 Other diseases of blood and blood-forming organs
    289.5 Other diseases of spleen
        289.50 Spleen disease NOS
        289.51 Chr congest splenomegaly
        289.52 Splenic sequestration
        289.53 Neutropenic splenomegaly
        289.59 Spleen disease NEC
    289.8 Other specified diseases of blood and blood-forming organs
        289.83 Myelofibrosis
OTHER SPECIFIED PERSONAL EXPOSURES AND HISTORY PRESENTING HAZARDS TO HEALTH (V87)
V87 Other specified personal exposures and history presenting hazards to health
    V87.4 Personal history of drug therapy
        V87.41 Hx antineoplastic chemo
        V87.42 Hx monoclonal drug thrpy
        V87.44 Hx inhaled steroid thrpy
        V87.45 Hx systemc steroid thrpy
        V87.46 Hx immunosuppres thrp
OTHER METABOLIC AND IMMUNITY DISORDERS (270-279)
273 Disorders of plasma protein metabolism
    273.0 Polyclon hypergammaglobu
    273.1 Monoclon paraproteinemia
    273.2 Paraproteinemia NEC
277 Other and unspecified disorders of metabolism
    277.2 Purine/pyrimid dis NEC ## ADA/PNP deficiency
    277.6 Defic circul enzyme NEC ## Biotinase deficiency
NEED FOR ISOLATION FOR OTHER ... HAZARDS ... AND PROPHYLAXIS ... (V07-V09)
V07 Need for isolation and other prophylactic or treatment measures
    V07.0 Prophylactic isolation
    V07.2 Prophylact immunotherapy
    V07.3 Other prophylactic chemotherapy
        V07.31 Prophylac fluoride admin
        V07.39 Other prophylac chemothr
    V07.8 Prophyl or tx meas NEC
    V07.9 Prophyl or tx meas NOS
PERSONS WITH A CONDITION INFLUENCING THEIR HEALTH STATUS (V40-V49)
V42 Organ or tissue replaced by transplant
    V42.0 Kidney transplant status
    V42.1 Heart transplant status
    V42.2 Heart valve transplant
    V42.3 Skin transplant status
    V42.4 Bone transplant status
    V42.5 Cornea transplant status
    V42.6 Lung transplant status
    V42.7 Liver transplant status
    V42.8 Other specified organ or tissue transplant
        V42.81 Trnspl status-bne marrow
        V42.82 Trspl sts-perip stm cell
        V42.83 Trnspl status-pancreas
        V42.84 Trnspl status-intestines
        V42.89 Trnspl status organ NEC
    V42.9 Transplant status NOS
PERSONS ENCOUNTERING HEALTH SERVICES FOR SPECIFIC PROCEDURES ... (V50-V59)
V58.0 Radiotherapy encounter
V58.1 Encounter for antineoplastic chemotherapy and immunotherapy
    V58.11 Antineoplastic chemo enc
    V58.12 Immunotherapy encounter
V58.2 Blood transfusion, no dx
V58.4 Other aftercare following surgery
    V58.42 Aftercare neoplasm surg
    V58.44 Aftercare organ transplt
V58.6 Long-term (current) drug use
    V58.64 Long-term anti-inflamtry
    V58.65 Long-term use steroids
    V58.69 Long-term use meds NEC ## Common code for infection r/t chemo
    V58.83 Therapeutic drug monitor ## Common with V58.61-V58.69 and V42
MISCELLANEOUS DIAGNOSTIC AND THERAPEUTIC PROCEDURES (87-99)
99 Other nonoperative procedures
    99.2 Injor infusion of other therapeutic or prophylactic substance
        99.28 Injection or infusion of BRM as an antineopl
DRUGS, MED AND BIO SUBSTANCES CAUSING ADVERSE EFF ... (E930-E949)
E932 Hormones and synthetic substitutes causing adverse effects
    E932.0 Adv eff corticosteroids
E933 Primarily systemic agents causing adverse effects
    E933.1 Adv eff antineoplastic
E935 Analgesics, antipyretics, and antirheumatics causing adverse effects
    E935.5 Adv eff pyrazole deriv
    E935.6 Adv eff antirheumatics
## Search terms
## ## Etiologies and corelates
Cushing's syndrome 255.0
Pois-corticosteroids 962.0
Pneum in aspergillosis 484.6
Polyclonal hypergammaglobulinemia 273.0
Cryoglobulinemia 273.2
Hypergammaglobulinemia, unspecified 273.1 or 289.89
Immune reconstitution syndrome 279.8
Mast cell activation, unspecified 279.8
Monoclonal mast cell activation syndrome 279.8
Idiopathic mast cell activation syndrome 279.8
Secondary mast cell activation 279.8
Acute graft-versus-host disease 279.51
Chronic graft-versus-host disease 279.52
Acute on chronic graft-versus-host disease 279.53
Graft-versus-host disease, unspecified 279.50
Autoimmune lymphoproliferative syndrome [ALPS] 279.41
specified disorders involving the immune mechanism, not elsewhere classified 279.8
Disorder involving the immune mechanism, unspecified 279.9
Polycythemia vera, Myelodysplasia, Fanconis disease, Idiopathic aplasia
Lymphoma, Leukemia, HIV infection




#####################
## Steroid therapy ##
#####################
## ICD-9-CM Vol. 1
POISONING BY DRUGS, MEDICINAL AND BIOLOGICAL SUBSTANCES (960-979)
962 Poisoning by hormones and synthetic substitutes
    962.0 Pois-corticosteroids
MISCELLANEOUS DIAGNOSTIC AND THERAPEUTIC PROCEDURES (87-99)
99 Other nonoperative procedures
    99.2 Injection or infusion of other therapeutic or prophylactic substance 
        99.23 Injection of steroid
DISEASES OF OTHER ENDOCRINE GLANDS (249-259)
255 Disorders of adrenal glands
    255.0 Cushings syndrome
    255.1 Hyperaldosteronism
        255.10 Hyperaldosteronism NOS
        255.11 Glucrtcod-rem aldsternsm
        255.12 Conn's syndrome
        255.13 Bartter's syndrome
        255.14 Secondry aldosternsm NEC
    255.2 Adrenogenital disorders
    255.3 Corticoadren overact NEC
    255.4 Corticoadrenal insufficiency
        255.41 Glucocorticoid deficient
        255.42 Mineralcorticoid defcnt
    255.5 Adrenal hypofunction NEC
    255.6 Medulloadrenal hyperfunc
    255.8 Adrenal disorder NEC
    255.9 Adrenal disorder NO
DISORDERS OF THE EYE AND ADNEXA (360-379)
365 Glaucoma
    365.3 Corticosteroid-induced glaucoma
V87.44 Hx inhaled steroid thrpy
V87.45 Hx systemc steroid thrpy
## MIMIC-III
## ## DRGCODES.DRG_TYPE
## ## ## HCFA codes
## ## ## APR codes
## ## ## MS codes
## ## PRESCRIPTIONS.GSN
## ## PRESCRIPTIONS.NCD




##################
## Chemotherapy ##
##################
## ICD-9-CM Vol. 1
MISCELLANEOUS DIAGNOSTIC AND THERAPEUTIC PROCEDURES (87-99)
99 Other nonoperative procedures
    99.2 Inj or inf of other therapeutic or prophylactic substance
        99.25 Inj or inf of cancer chemotherapeutic substance
        99.28 Inj or infusion of BRM as an antineopl
DISEASES OF THE BLOOD AND BLOOD-FORMING ORGANS (280-289)
284 Aplastic anemia and other bone marrow failure syndromes
    284.1 Pancytopenia
        284.11 Antineo chemo indcd pancyt
285 Other and unspecified anemias
    285.3 Anemia d/t antineo chemo
COMPLICATIONS OF SURGICAL AND MEDICAL CARE NOC (996-999)
999 Complications of medical care, not elsewhere classified
    999.8 Other and unspecified infusion and transfusion reaction
        999.81 Extravstn vesicant chemo
PERSONS ENCOUNTERING HEALTH SERVICES FOR SPECIFIC PROCEDURES AND AFTERCARE (V50-V59)
V58 Encounter for other and unspecified procedures and aftercare
    V58.1 Encounter for antineoplastic chemotherapy and immunotherapy
        V58.11 Antineoplastic chemo enc
        V58.12 Immunotherapy encounter
PERSONS ENCOUNTERING HEALTH SERVICES IN OTHER CIRCUMSTANCES (V60-V69)
V66 Convalescence and palliative care
    V66.2 Chemotherapy convalescen
    V67.2 Chemotherapy follow-up
NEED FOR ISOLATION FOR OTHER ... HAZARDS & PROPHYLACTIC MEASURES (V07-V09)
V07 Need for isolation and other prophylactic or treatment measures
    V07.2 Prophylact immunotherapy
    V07.3 Other prophylactic chemotherapy
        V07.31 Prophylac fluoride admin
        V07.39 Other prophylac chemothr
OTHER SPECIFIED EXPOSURES AND HX PRESENTING HAZARDS TO HEALTH (V87)
    V87 Other specified exposures and hx presenting hazards to health
        V87.4 Personal history of drug therapy
            V87.41 Hx antineoplastic chemo




############################################
## Renal replacement therapy on admission ##
############################################




#########################
## Sepsis on admission ##
#########################



